UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Trimmed by J. W. Coons Advisors LLC

J. W. Coons Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,462 shares of the healthcare conglomerate’s stock after selling 104 shares during the period. UnitedHealth Group comprises 1.3% of J. W. Coons Advisors LLC’s investment portfolio, making the stock its 9th largest position. J. W. Coons Advisors LLC’s holdings in UnitedHealth Group were worth $4,982,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the fourth quarter worth $26,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. LFA Lugano Financial Advisors SA lifted its position in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. O Brien Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 36.8% in the fourth quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock worth $41,000 after buying an additional 21 shares during the period. Finally, Friedenthal Financial purchased a new stake in UnitedHealth Group during the 4th quarter valued at $42,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $490.52 on Friday. The stock has a 50-day moving average of $490.35 and a 200 day moving average of $508.04. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $451.47 billion, a price-to-earnings ratio of 29.98, a PEG ratio of 1.46 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the firm posted $6.26 EPS. The firm’s revenue was up 8.6% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 17th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.71%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Monday, June 17th. UnitedHealth Group’s payout ratio is 45.97%.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 31st. JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Robert W. Baird initiated coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $578.75.

View Our Latest Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.